Astria Therapeutics, Inc.ATXSNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.01
Net Income/Share$-2.14
Operating CF/Share$-2.06
Free CF/Share$-2.07
Cash/Share$3.93
Book Value/Share$4.02
Tangible Book/Share$4.02
Equity/Share$4.02
Interest Debt/Share$0.08
CapEx/Share$0.01
Dividend/Share$0.00
Valuation
Market Cap$718.13M
Enterprise Value$626.31M
P/E Ratio-5.88P/S Ratio1,017.18P/OCF Ratio-6.09
P/FCF Ratio-5.97
P/B Ratio3.13P/TB Ratio3.13
EV/Sales887.12EV/EBITDA-4.67
Graham Valuation
Graham Number--
Graham Net-Net$3.48
Profitability
Earnings Yield-17.00%FCF Yield-16.76%ROE-45.01%ROIC-54.66%Return on Tangible Assets-45.62%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.49%
CapEx/Revenue83.57%
CapEx/Depreciation-0.31
SBC/Revenue2252.27%
SG&A/Revenue5524.93%
R&D/Revenue13886.83%
Liquidity & Solvency
Debt/Equity0.02Debt/Assets0.02Debt/Market Cap0.01
Net Debt/EBITDA0.68
Current Ratio10.78Interest Coverage0.00xIncome Quality0.97Efficiency
Days Sales Outstanding8915 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover0.04x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$233.25M
Working Capital$230.03M
Invested Capital$234.28M
Intangibles/Assets0.00%